Spectral Medical Enrolls Patient 82 in Its Phase 3 FDA Tigris Septic Shock Trial
January 10, 2024 07:00 ET
|
Spectral Medical Inc.
New patient enrollment sites accelerating screening activityScreening activity exceeding 100 patients per weekApproaching interim enrollment target of 90 patients TORONTO, Jan. 10, 2024 (GLOBE...
Spectral Medical Provides Tigris Trial Update
December 14, 2023 08:00 ET
|
Spectral Medical Inc.
81 patients enrolled TORONTO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...
Spectral Medical Provides November Tigris Trial Update
December 04, 2023 08:00 ET
|
Spectral Medical Inc.
79 patients enrolled TORONTO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...
Spectral Medical Announces CFO Departure
December 01, 2023 08:00 ET
|
Spectral Medical Inc.
TORONTO, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces Publication of Tigris Trial Methods Paper and Simulation of Results
November 14, 2023 08:00 ET
|
Spectral Medical Inc.
TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces Third Quarter Results and Provides Corporate Update
November 09, 2023 08:00 ET
|
Spectral Medical Inc.
Tigris Trial Enrollment Reaches 76 PatientsCrude mortality results continue to exceed expectations TORONTO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”)...
Spectral Medical Provides Tigris Trial Update
November 07, 2023 08:00 ET
|
Spectral Medical Inc.
• 76 patients enrolled • Emory Healthcare latest clinical site addition into the Tigris Trial TORONTO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:...
Spectral Medical Announces Opening of Tigris Clinical Trial Site at the Mayo Clinic
October 16, 2023 08:00 ET
|
Spectral Medical Inc.
TORONTO, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Provides Tigris Trial Update
October 03, 2023 08:00 ET
|
Spectral Medical Inc.
74 patients enrolledNew sites to further accelerate patient enrollmentOn track to onboard seven new trial sites around the end of November 2023 TORONTO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Spectral...
Spectral Medical Provides Board Update
October 02, 2023 08:00 ET
|
Spectral Medical Inc.
TORONTO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...